Literature DB >> 1305685

Natural history of early bladder cancer.

D G Bostwick1.   

Abstract

Non-invasive transitional cell carcinoma (TCC) occurs as two distinct growth patterns, papillary and non-papillary (flat), which display significant differences in biologic potential. Papillary carcinoma usually presents as a low-grade lesion which frequently recurs multiple times prior to invasion; conversely, non-papillary (flat) carcinoma in situ is usually high-grade at presentation (carcinoma in situ) and frequently associated with invasion. These lesions may occur together, although papillary cancer is more easily visualized cystoscopically due to its exophytic growth; flat carcinoma in situ is often cystoscopically invisible. This report reviews existing data concerning the prognostic value of pathologic grading and staging of non-invasive and early invasive TCC. Emphasis is placed on those studies reporting surgical treatment rather than other forms of treatment.

Entities:  

Mesh:

Year:  1992        PMID: 1305685     DOI: 10.1002/jcb.240501307

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN: 0733-1959


  6 in total

1.  Progressive loss of CD44 gene expression in invasive bladder cancer.

Authors:  T Sugino; H Gorham; K Yoshida; J Bolodeoku; V Nargund; D Cranston; S Goodison; D Tarin
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

2.  Update on the management of non-muscle invasive bladder cancer.

Authors:  Saad Aldousari; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

Review 3.  Grading Systems for Canine Urothelial Carcinoma of the Bladder: A Comparative Overview.

Authors:  Eleonora Brambilla; Veronica M Govoni; Alexandre Matheus Baesso Cavalca; Renée Laufer-Amorim; Carlos Eduardo Fonseca-Alves; Valeria Grieco
Journal:  Animals (Basel)       Date:  2022-06-04       Impact factor: 3.231

4.  Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.

Authors:  Erik Pasin; David Y Josephson; Anirban P Mitra; Richard J Cote; John P Stein
Journal:  Rev Urol       Date:  2008

5.  Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies.

Authors:  Isil Z Yildiz; Rosemary Recavarren; Henry B Armah; Sheldon Bastacky; Rajiv Dhir; Anil V Parwani
Journal:  Diagn Pathol       Date:  2009-10-14       Impact factor: 2.644

Review 6.  Superficial bladder cancer.

Authors:  Donald L Lamm
Journal:  Curr Treat Options Oncol       Date:  2002-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.